Clinical Trial Update: CT 327 in the "Atopy Patch Test" Model [Phase 1]

View source ↗

Summary

Phase 1 trial CT 327 for atopic dermatitis using the Atopy Patch Test model has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CT 327

Snippet

Sponsor: Creabilis SA | Conditions: Atopic Dermatitis | Phase 1 | Status: WITHDRAWN